Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corporate Communications
LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and...
Month: May 2022
Denali Therapeutics and Biogen Announce Initiation of Phase 2b Study of LRRK2 Inhibitor in Parkinson’s Disease
BIIB122 is an inhibitor of LRRK2, a potential novel target intended to impact the underlying biology and slow the progression...
Nasdaq Confirms Continued Listing of Eargo Stock
SAN JOSE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (the “Company” or “Eargo”), a medical device...
Ayujoy Herbals Ltd. and Anthea, Inc. Announce Product Sourcing and Marketing Collaboration
Ayujoy Herbals Ltd. and Anthea, Inc. Announce Product Sourcing and Marketing Collaboration MAG Mountain WaterBerlin, Germany, May 31, 2022 (GLOBE...
PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe
Promising preliminary clinical results validate expansion of study initially into the United KingdomFLORHAM PARK, N.J., May 31, 2022 (GLOBE NEWSWIRE)...
Compass Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference
BOSTON, May 31, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics...
Cullinan Oncology to Present Updated Data Demonstrating the Therapeutic Potential of CLN-081 in Patients with EGFR Exon 20 Insertion Mutation Positive Non-Small Cell Lung Cancer at the 2022 ASCO Annual Meeting
Updated data from Phase 1/2a study show median duration of response greater than 21 months and median progression-free survival of...
Scientific Leaders Agree on Promise of Enochian BioSciences
LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) - Enochian BioSciences is working to solve our greatest public...
Sight Sciences’ OMNI® Surgical System Reduces IOP, Daily Fluctuations in IOP and Medication Use, as Shown in Newly Published 12-Month Clinical Data
Suppression of diurnal, or daily, fluctuations in IOP, is a significant and independent risk factor for the progression of glaucomaThese...
Enlivex Announces New Preclinical Data in Ovarian Cancer Showing a Substantial Survival Benefit when Allocetra is Combined with PD-1 Checkpoint Inhibition at the American Society of Clinical Oncology (ASCO) Annual Meeting
Ovarian Cancer ID8 Study – Survival Probability Source imageStand-alone therapy with PD1 checkpoint inhibitors has shown limited efficacy against ovarian...
Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results
LAKEWOOD, Colo., May 31, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q22”)...
Axsome Therapeutics Announces Publication of Pivotal GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder in The Journal of Clinical Psychiatry
AXS-05 (dextromethorphan-bupropion) demonstrated rapid, substantial, and statistically significant antidepressant efficacy compared to placebo starting 1 week after treatmentNEW YORK, May...
Theratechnologies Announces New Head of Investor Relations
MONTREAL, May 31, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or “the Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company...
Brooklyn ImmunoTherapeutics Announces Changes to Executive Management: Matt Angel, Ph.D. Appointed Interim Chief Executive Officer and President, Andrew Jackson Appointed Chief Financial Officer Postpones 2022 Annual Meeting
SAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused...
Altimmune to Present Pemvidutide Clinical Data at Upcoming American Diabetes Association Scientific Sessions June 6, 2022
GAITHERSBURG, Md., May 31, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr....
Jushi Holdings Inc. Announces Participation in Upcoming Conference and Event in June 2022
BOCA RATON, Fla., May 31, 2022 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF),...
TG Therapeutics Announces FDA Extension of BLA PDUFA Date for Ublituximab to Treat Patients with RMS
New PDUFA goal date of December 28, 2022NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today...
Bloom Health Partners Reports Profitable Fiscal Q2 2022 with $11.1 Million in Revenue
Vancouver, British Columbia--(Newsfile Corp. - May 31, 2022) - Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom"...
LevelJump Announces Record Revenues from Operations; Q1 Revenue Increase of 27%; Q1 2022 Earnings and Results
Toronto, Ontario--(Newsfile Corp. - May 31, 2022) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the...
Lophos Pharmaceuticals Corp. CEO Claire Stawnyczy Presenting at O’Cannabiz Psychedelics Summit – June 2nd
Napanee, Ontario--(Newsfile Corp. - May 31, 2022) - Lophos Pharmaceuticals Corp., a Canadian biosciences research and development company that focuses...